Pankti D Reid (Pankti Reid)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Rheumatoid Arthritis

Interstitial Lung Disease

Top Venues

Pharmaceuticals (Basel, Switzerland)

Expert review of clinical immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Sharjeel Syed, Jacobi Hines, Rachel Baccile, Sherin Juliet Rouhani, Pankti D Reid
Studying Outcomes after Steroid-Sparing Immunosuppressive Agent vs. Steroid-Only Treatment for Immune-Related Adverse Events in Non-Small-Cell Lung Cancer (NSCLC) and Melanoma: A Retrospective Case-Control Study. Cancers 16 (10) (2024)
Sharjeel Syed, Jacobi Hines, Rachel Baccile, Sherin Juliet Rouhani, Pankti D Reid
Studying Outcomes after Steroid-Sparing Immunosuppressive Agent vs. Steroid-Only Treatment for Immune-Related Adverse Events in Non-Small-Cell Lung Cancer (NSCLC) and Melanoma: A Retrospective Case-Control Study. Cancers 16 (10) (2024)
Hans Vitzthum von Eckstaedt, Arohi Singh, Pankti D Reid, Kimberly Trotter
Immune Checkpoint Inhibitors and Lupus Erythematosus. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Hans Vitzthum von Eckstaedt, Arohi Singh, Pankti D Reid, Kimberly Trotter
Immune Checkpoint Inhibitors and Lupus Erythematosus. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Pankti D Reid, Sabina Sandigursky, Juhee Song, Maria A Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S Weber, Osama E Rahma, Maria E Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology 12 (1) (2023)
Victor Yang, Tue Wenzel Kragstrup, Christopher R McMaster, Pankti D Reid, Namrata Singh, Stine R Haysen, Philip C Robinson, David F L Liew
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors. Drug safety (2023)
Pankti D Reid, Sabina Sandigursky, Juhee Song, Maria A Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S Weber, Osama E Rahma, Maria E Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology 12 (1) (2023)
Pankti D Reid, Sabina Sandigursky, Juhee Song, Maria A Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S Weber, Osama E Rahma, Maria E Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology 12 (1) (2023)
Pankti D Reid, Sabina Sandigursky, Juhee Song, Maria A Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S Weber, Osama E Rahma, Maria E Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology 12 (1) (2023)
Kristen Mathias, Sherin Juliet Rouhani, Daniel Olson, Anne R Bass, Thomas F Gajewski, Pankti D Reid
Association Between Rheumatic Autoantibodies and Immune-Related Adverse Events. The oncologist (2023)
Kate Tokareva, Pankti D Reid, Victor Yang, David F L Liew, Alexander C Peterson, Aaron Baraff, Jon Giles, Namrata Singh
JAK inhibitors and black box warnings: what is the future for JAK inhibitors? Expert review of clinical immunology (2023)
Pankti D Reid, Sabina Sandigursky, Juhee Song, Maria A Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S Weber, Osama E Rahma, Maria E Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology 12 (1) (2023)
Pankti D Reid, Sabina Sandigursky, Juhee Song, Maria A Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S Weber, Osama E Rahma, Maria E Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology 12 (1) (2023)
Pankti D Reid, Sabina Sandigursky, Juhee Song, Maria A Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S Weber, Osama E Rahma, Maria E Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology 12 (1) (2023)
Pankti D Reid, Sabina Sandigursky, Juhee Song, Maria A Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S Weber, Osama E Rahma, Maria E Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology 12 (1) (2023)
Austin Wesevich, Gong He, Greg Tomczyk, Pankti D Reid
Role-Specific Curricular Needs for Identification and Management of Immune-Related Adverse Events. Journal of cancer education : the official journal of the American Association for Cancer Education (2023)
Michael Macklin, Sudeep Yadav, Reem Jan, Pankti D Reid
Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Anne R Bass, Noha Abdel-Wahab, Pankti D Reid, Jeffrey A Sparks, Cassandra Calabrese, Deanna P Jannat-Khah, Nilasha Ghosh, Divya Rajesh, Carlos Andres Aude, Lydia Gedmintas, Lindsey MacFarlane, Senada Arabelovic, Adewunmi Falohun, Komal Mushtaq, Farah Al Haj, Adi Diab, Ami A Shah, Clifton O Bingham, Karmela Kim Chan, Laura C Cappelli
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis. Annals of the rheumatic diseases (2023)
Pankti D Reid, Sabina Sandigursky, Juhee Song, Maria A Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S Weber, Osama E Rahma, Maria E Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology 12 (1) (2023)
Pankti D Reid, David F L Liew, Rajshi Akruwala, Anne R Bass, Karmela K Chan
Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study. Journal for immunotherapy of cancer 9 (9) (2022)
Pankti D Reid, Sabina A Guler
Mortality Trends in Rheumatoid Arthritis: Zooming in on Interstitial Lung Disease. Annals of the American Thoracic Society 18 (12) (2021)
Garth W Strohbehn, Brian L Heiss, Sherin Juliet Rouhani, Jonathan A Trujillo, Jovian Yu, Alec J Kacew, Emily F Higgs, Jeffrey C Bloodworth, Alexandra Cabanov, Rachel C Wright, Adriana Koziol, Alexandra Weiss, Keith Danahey, Theodore G Karrison, Cuoghi C Edens, Iazsmin Bauer Ventura, Natasha N Pettit, Bhakti Patel, Jennifer Pisano, Mary E Strek, Thomas F Gajewski, Mark J Ratain, Pankti D Reid
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19. medRxiv : the preprint server for health sciences (2020)
Pankti D Reid, Eli M Miloslavsky, Anisha Dua
Teacher training for rheumatology fellows: a national needs assessment of fellows and program directors. Clinical rheumatology 39 (3) (2019)